Aprea Therapeutics, Inc.
APRE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001781983
No open-market purchases or sales by Aprea Therapeutics, Inc. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $1.90M in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in Aprea Therapeutics, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 26
- +4 vs. Q3 2024
- Shares held
- 2.08M
- +76.3K (+3.8%) vs. Q3 2024
- Total value
- $6.83M
- +$1.33M (+24.1%) vs. Q3 2024
- New holders
- 5
- 5 more added
- Sold out
- 1
- 4 more reduced
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting APRE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 27 | $1.90M |
| Q1 2026 | 22 | $1.71M |
| Q4 2025 | 22 | $1.45M |
| Q3 2025 | 23 | $2.39M |
| Q2 2025 | 23 | $3.07M |
| Q1 2025 | 26 | $3.78M |
| Q4 2024 | 26 | $6.83M |
| Q3 2024 | 22 | $5.50M |
| Q2 2024 | 28 | $8.48M |
| Q1 2024 | 24 | $10.8M |
| Q4 2023 | 20 | $4.36M |
| Q3 2023 | 21 | $3.66M |
| Q2 2023 | 19 | $2.78M |
| Q1 2023 | 18 | $3.77M |
| Q4 2022 | 25 | $521.3K |
| Q3 2022 | 27 | $1.11M |
| Q2 2022 | 34 | $1.52M |
| Q1 2022 | 40 | $4.50M |
| Q4 2021 | 41 | $10.4M |
| Q3 2021 | 39 | $25.6M |
| Q2 2021 | 50 | $31.9M |
| Q1 2021 | 67 | $45.4M |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Aprea Therapeutics, Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| JPMorgan Chase & Co | 11 | $36 | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 24 | $79 | 0.00% | +24 | New |
| SBI Securities Co., Ltd. | 40 | $132 | 0.00% | +40 | New |
| Advisor Group Holdings, Inc. | 100 | $329 | 0.00% | −50−33.3% | Reduced |
| WealthCollab, LLC | 158 | $520 | 0.00% | 00.0% | Unchanged |
| MB, Levis & Associates, LLC | 806 | $2.65K | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 824 | $2.70K | 0.00% | −1,336−61.9% | Reduced |
| Tower Research Capital LLC (TRC) | 1,478 | $4.86K | 0.00% | +163+12.4% | Added |
| Bank of America Corp | 4,851 | $16.0K | 0.00% | −10.0% | Reduced |
| UBS Group AG | 5,935 | $19.5K | 0.00% | +5,932+197,733.3% | Added |
| BlackRock, Inc. | 8,504 | $28.0K | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 13,011 | $42.7K | 0.00% | +13,011 | New |
| HighTower Advisors, LLC | 13,864 | $45.6K | 0.00% | 00.0% | Unchanged |
| LPL Financial LLC | 16,052 | $52.8K | 0.00% | +16,052 | New |
| Dimensional Fund Advisors LP | 17,064 | $56.0K | 0.00% | 00.0% | Unchanged |
| Landscape Capital Management, L.L.C. | 35,328 | $116.2K | 0.01% | +35,328 | New |
| Morgan Stanley | 36,808 | $121.1K | 0.00% | +2,600+7.6% | Added |
| Geode Capital Management, LLC | 42,663 | $140.0K | 0.00% | +2,596+6.5% | Added |
| Exome Asset Management LLC | 127,960 | $419.7K | 0.32% | −9,214−6.7% | Reduced |
| DAFNA Capital Management LLC | 137,174 | $451.3K | 0.11% | 00.0% | Unchanged |
| Stonepine Capital Management, LLC | 149,221 | $490.9K | 0.40% | +12,047+8.8% | Added |
| Vanguard Group Inc | 173,842 | $570.2K | 0.00% | 00.0% | Unchanged |
| Nantahala Capital Management, LLC | 205,760 | $677.0K | 0.05% | 00.0% | Unchanged |
| Sphera Funds Management Ltd. | 270,000 | $888.3K | 0.16% | 00.0% | Unchanged |
| Sio Capital Management, LLC | 276,603 | $910.0K | 0.26% | 00.0% | Unchanged |
| AIGH Capital Management LLC | 539,300 | $1.77M | 0.67% | 00.0% | Unchanged |
| NBC Securities, Inc. | 0 | $0 | 0.00% | −899−100.0% | Sold out |